Related Experiment Videos

Diagnostic efficacy of monocyte distribution width to high-sensitivity C-reactive protein ratio in differentiating

Rong Yu1, Hua Tang2

  • 1Clinical Laboratory, The Second Hospital of Hunan University of Chinese Medicine, Changsha City, Hunan, China.

Abstract

Insights

The monocyte distribution width to high-sensitivity C-reactive protein ratio (MDW/hs-CRP) effectively differentiates bacterial from viral community-acquired pneumonia (CAP). This novel biomarker aids rapid antimicrobial decisions in emergency departments.

Area of Science:

  • Medical diagnostics
  • Infectious disease research
  • Biomarker discovery

Background:

  • Community-acquired pneumonia (CAP) diagnosis is challenging in emergency settings.
  • Accurate pathogen identification is crucial for effective antimicrobial therapy and stewardship.
  • Existing biomarkers lack sufficient accuracy for differentiating CAP pathogens.

Purpose of the Study:

  • To evaluate the diagnostic accuracy of the monocyte distribution width to high-sensitivity C-reactive protein ratio (MDW/hs-CRP) for differentiating bacterial, viral, atypical, and mixed CAP pathogens.
  • To compare the MDW/hs-CRP ratio's performance against individual biomarkers.

Main Methods:

  • Retrospective cohort study of 486 adult patients with radiologically confirmed CAP.
  • Pathogen identification via comprehensive microbiological testing.
  • MDW measured by automated hematology analyzer; hs-CRP by standard assays.
  • Diagnostic accuracy assessed using ROC analysis, Youden index, and decision curve analysis (DCA).

Main Results:

  • The MDW/hs-CRP ratio achieved an AUC of 0.893 for distinguishing bacterial from viral CAP, significantly outperforming MDW (AUC 0.752) and hs-CRP (AUC 0.798).
  • Optimal cutoff (0.185) provided 85.4% sensitivity and 82.7% specificity.
  • DCA indicated clinical utility across a range of threshold probabilities.

Conclusions:

  • The MDW/hs-CRP ratio demonstrates potential as a rapid diagnostic tool for CAP pathogen differentiation.
  • This biomarker may assist in optimizing early antimicrobial treatment decisions in emergency care.
  • Further multicenter validation is recommended.